Good decisions require good information
Find hidden gems and smart strategies from top experts when you join Seeking Alpha.
VIRI Virios Therapeutics, Inc.Stock Price & Overview
$0.22
Charts
Quant Ranking
VIRI Analysis
VIRI News
Latest Headlines
Ratings Summary
People Also Follow
Similar to VIRI
ETFs Holding VIRI
VIRI Company Profile
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company’s lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
VIRI Revenue
VIRI Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Profitability
Momentum
Capital Structure
Dividends
VIRI Ownership
VIRI Peers
Risk
Technicals
VIRI Transcripts
Investor Presentations
VIRI SEC Filings
Press Releases
VIRI Income Statement
VIRI Balance Sheet
VIRI Cash Flow Statement
Discover More
You may be interested in: